India's IOL Chemicals and Pharma up after getting drug export nods
** Shares of India's IOL Chemicals and Pharmaceuticals
IOLC.NS up 4.2% after jumping as much as 6.3% earlier in the
session
** Pharmaceuticals and chemicals maker gets nods from
European Directorate for the Quality of Medicines & Health Care
(EDQM) to export two drugs
Drug name Used to treat
Uric acid, gout and joint pain
Allopurinol
Heartburn, gastro-oesophageal
Pantoprazole Sodium reflux disease
Sesquihydrate
** Trading vols 7.6x 30-day avg in busiest session since
March 19
** YTD stock has fallen ~15% after climbing 24% in 2023
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on IOL Chemicals and Pharmaceuticals
See all newsBrief: Iol Chemicals And Pharmaceuticals Says European Directorate For Quality Of Medicines & Healthcare Grants Certificate For Fenofibrate–Process II
Brief: IOL Chemicals And Pharmaceuticals June-Quarter Consol Profit 644 Million Rupees
Brief: IOL Chemicals and Pharmaceuticals Gets Approval From NMPA, China For Clopidogrel Bisulfate API
Brief: IOL Chemicals And Pharmaceuticals Reports Minor Fire Incident In Unit-9B Minoxidil Manufacturing Unit On June 9
Brief: IOL Chemicals And Pharmaceuticals March-Quarter Consol Profit 531.6 Million Rupees